Methods  Retrospective review and characterisation of CDS alerts recorded in the EP system over 1 year. Results  A total of 16 182 conflict alerts were recorded when ordering 26 836 items, of which 3507 (13 alerts per 100 prescription orders (95% confidence interval, 12.8 to 13.6)) were visible to the user. Eighty nine percent (3119/3507) of all visible alerts were overridden by the user at point of prescribing.

Drug-allergy conflict alerts were the most accepted, and exact drug duplication alerts the least. Conclusion  We found a high incidence of alert override, which is undesirable but consistent with that reported in the literature. The results suggest that the underlying learn more algorithms for alert generation in many EP systems are not specific and need to be reviewed. “
“This study measures the extent of drug substitution associated with a hospital stay in Belgium. Data were extracted from the 2006–2007 dataset of the Belgian Agency of Health Insurance Funds on drug use of patients hospitalized in acute hospitals. Reimbursed drugs received

in ambulatory care during the 3 months prior to hospitalization were compared with drugs received during the 3 months following hospital discharge. Both a narrow definition and a broad definition were used for drug substitution. Narrow substitution (switches between generic and originator drugs) was computed for 14 drug classes for chronic conditions Verteporfin in vitro with the highest public expenditure. Broad substitution (changes between chemical substances within the drug class at ATC level 4, changes in brand name) was calculated GSK-3 beta phosphorylation for statins and proton-pump inhibitors only. The database included 17 764 patients (mean age 66 ± 17 years; 60% female). In 71% of cases an originator drug was received prior to and following hospitalization. A generic drug was received prior to and following hospitalization in 25% of cases. Some form of narrow substitution occurred in 4% of cases: a generic drug was replaced by an originator drug in 2% of cases

and an originator drug was replaced by a generic drug in 2% of cases. Some form of broad substitution occurred in 25% of cases for proton-pump inhibitors and 13% of cases for statins. Hospitalization was not a trigger for changes between originator and generic versions of a drug. Broad substitution associated with a hospital stay was relatively limited for statins and proton-pump inhibitors. “
“Objectives  Previous studies have revealed a range of drug-related problems for nursing home and hospital patients. Different attempts to reduce drug-related problems have been tested. Medication reviews performed by pharmacists and subsequent presentation of findings at case conferences is one of these methods. Physicians’ and nurses’ experiences from multidisciplinary collaboration with pharmacists have to a lesser degree been investigated.